A total of 15 products were added in the month from six different brands: Actis, Amundi, Brookfield, Global X, M&G, and Mirae.
CCR Monthly Approval Report – June 2022
A total of nine products were added in the month from five different asset managers: Fidelity, DWS, Fullerton, Liontrust, PineBridge and Exeter Property Group.
CCR Monthly Approval Report – July 2022
A total of 34 products were added in the month from eight different asset managers: Eaton Vance, GAM, Greystar, Invesco, Jupiter, Manulife, PIMCO and UBS.
CCR suspends some Allianz funds in Chile on heels of SEC charges
Market actors said they did not see fraud charges in the US impacting the firm's success in Chile.
After eight months waiting, the Afores have a new list of funds to choose from
Amafore’s Alvaro Meléndez shared the changes related to the approval of international mutual funds for the Afores to invest in, as well as an updated list of funds.
CCR Monthly Approval Report – May 2022
T. Rowe Price led with nine products registered, while Credicorp Capital, Eastspring, Invesco, Silver Lake and Veritas Capital completed the list. each with one product approved.
CCR Monthly Approval Report – April 2022
BlackRock and Lazard led, both with three mutual funds approved in the month, while Jupiter, UBS and State Street with one product each completed the list.
CCR Monthly Approval Report – March 2022
Nordea lead with four equity funds approved, followed by Bci, Candriam, JSS, Schroders, Vontobel and Arcano with one product each.
CCR Monthly Approval Report – February 2022
A total of 15 products were added in the month from four different asset managers: iShares, Allianz, M&G and Vanguard.
CCR Monthly Approval Report – January 2022
Moneda, AlpInvest Partners, Astorg Partners , HarbourVest Partners and HG CP were the managers registering products in January 2022.